SCHEMBL1534565

SCHEMBL1534565

COc1ccc2c(=O)c(I)c(-c3ccccc3)oc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.74
KDM4E B2RXH2 7/20 0.74
CYP3A4 P08684 6/20 0.74
MAPT P10636 5/20 0.74
HPGD P15428 5/20 0.74
HSD17B10 Q99714 5/20 0.74
MEN1 O00255 3/20 0.74
KMT2A Q03164 3/20 0.74
THRB P10828 1/20 0.74
CYP2C9 P11712 2/20 0.62
CYP2C19 P33261 2/20 0.62
CYP1A2 P05177 1/20 0.62
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
TP53 P04637 2/20 0.60
CASP1 P29466 1/20 0.60
CASP7 P55210 1/20 0.60
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
MAOA P21397 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534543 0.89 ALDH1A1 (0.74) ALDH1A1KDM4ECYP3A4MAPTHPGD
3,7-Dimethoxyflavone SCHEMBL4278796 0.85 ALDH1A1 (1.00) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL28566115 0.85 ALDH1A1 (0.76) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL29768227 0.85 ALDH1A1 (0.76) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL27726517 0.85 ALDH1A1 (0.76) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL15676588 0.84 KDM4E (0.85) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL4650060 0.84 KDM4E (0.85) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL1534484 0.83 ALDH1A1 (0.52) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL1534460 0.82 MEN1 (0.58) ALDH1A1KDM4ECYP3A4MAPTHPGD
SCHEMBL1534593 0.79 MEN1 (0.48) ALDH1A1KDM4ECYP3A4MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR ALDH1A1 4088/4885KDM4E 1952/4885CYP3A4 2648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.